Results for tag: "Ivacaftor"

Ivacaftor is a drug used to treat cystic fibrosis, a genetic disorder that affects the lungs and digestive system. It is a potentiator of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, which helps to regulate the flow of salt and water in and out of cells. Ivacaftor is used to improve lung function and reduce the frequency of pulmonary exacerbations in patients with cystic fibrosis. It is also used to treat certain types of sinusitis and bronchitis. The Ivacaftor market is a rapidly growing segment of the respiratory drugs market. It is expected to benefit from the increasing prevalence of cystic fibrosis and the growing demand for effective treatments. The market is also expected to benefit from the increasing focus on research and development of new drugs for cystic fibrosis. Some of the major companies in the Ivacaftor market include Vertex Pharmaceuticals, GlaxoSmithKline, Merck & Co., and Novartis. These companies are engaged in the development and commercialization of Ivacaftor and other drugs for the treatment of cystic fibrosis. Show Less Read more